ArticleHand (New York, N.Y.)2026
Glucagon-Like Peptide-1 Receptor Agonist Use Is Associated With Increased Peripheral Nerve Compression After Bariatric Surgery.
Article in Hand (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGlucagon-like peptide-1 receptor agonists (GLP-1RAs) may reduce carpal tunnel syndrome (CTS) risk but are associated with acute compressive neuropathies after rapid weight loss ("slimmer's palsy"). This study evaluated upper-extremity nerve compression rates in patients with massive weight loss after bariatric surgery alone versus concurrent GLP-1RAs.
methodsA retrospective cohort study was conducted using the TriNetX US Collaborative Network. Adults who underwent bariatric surgery (January 2015-February 2026) were stratified by concurrent GLP-1RA therapy versus surgery alone. Propensity score matching (1:1) balanced baseline demographics and comorbidities. Primary outcomes were new CTS and cubital tunnel syndrome (CuTS). Secondary outcomes included surgical release and electrodiagnostic testing rates. Risk ratios (RRs) with 95% CIs were calculated.
resultsIn total, 11 158 patients were included in each cohort. The GLP-1RA group was younger (50.6 ± 12.2 vs 53.5 ± 14.3 years,
conclusionAdjunctive GLP-1RA therapy was associated with increased diagnoses of CTS and CuTS without higher surgical rates, suggesting greater susceptibility to nerve compression. Further studies are needed to clarify mechanisms and guide clinical monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.